Marketing-authorisation holder
Sandoz B.V.
1,137 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder
1,137 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 1,137
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Abacavir/Lamivudine Sandoz 600 mg/300 mg, filmomhulde tablettenFilmomhulde tablet | Abacavir, Lamivudine | Netherlands | Authorised | 2016 |
| Abacavir Sandoz 300 mg, filmomhulde tablettenFilmomhulde tablet | Abacavir | Netherlands | Authorised | 2016 |
| Abatixent 2,5 mg filmomhulde tablettenFilmomhulde tablet | Apixaban | Netherlands | Authorised | 2021 |
| Abatixent 5 mg filmomhulde tablettenFilmomhulde tablet | Apixaban | Netherlands | Authorised | 2021 |
| Abirateron Sandoz 1000 mg, filmomhulde tablettenFilmomhulde tablet | Abiraterone | Netherlands | Authorised | 2021 |
| Abirateron Sandoz 250 mg, filmomhulde tablettenFilmomhulde tablet | Abiraterone | Netherlands | Authorised | 2021 |
| Abirateron Sandoz 500 mg, filmomhulde tablettenFilmomhulde tablet | Abiraterone | Netherlands | Authorised | 2021 |
| Acetylcysteïne Sandoz 200 mg, granulaat voor drankGranulaat voor drank | Acetylcysteine | Netherlands | Authorised | 1998 |
| Acetylcysteïne Sandoz Bruis 600 mg, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 1997 |
| Aciclovir Sandoz tablet 200, tabletten 200 mgTablet | Aciclovir | Netherlands | Authorised | 1996 |
| Aciclovir Sandoz tablet 400, tabletten 400 mgTablet | Aciclovir | Netherlands | Authorised | 1996 |
| Aciclovir Sandoz tablet 800, tabletten 800 mgTablet | Aciclovir | Netherlands | Authorised | 1996 |
| Aclasta, oplossing voor infusie 5 mg/100 mlOplossing voor infusie | Zoledronic acid | Netherlands | Authorised | 2005 |
| Adimuplan 100 mg, filmomhulde tablettenFilmomhulde tablet | Sitagliptin | Netherlands | Authorised | 2021 |
| Adimuplan 25 mg, filmomhulde tablettenFilmomhulde tablet | Sitagliptin | Netherlands | Authorised | 2021 |
| Adimuplan 50 mg, filmomhulde tablettenFilmomhulde tablet | Sitagliptin | Netherlands | Authorised | 2021 |
| Adport 0,5 mg, capsules, hardCapsule, hard | Tacrolimus | Netherlands | Authorised | 2009 |
| Adport 0,75 mg, capsules, hardCapsule, hard | Tacrolimus | Netherlands | Authorised | 2014 |
| Adport 1 mg, capsules, hardCapsule, hard | Tacrolimus | Netherlands | Authorised | 2009 |
| Adport 2 mg, capsules, hardCapsule, hard | Tacrolimus | Netherlands | Authorised | 2014 |
| Adport 5 mg, capsules, hardCapsule, hard | Tacrolimus | Netherlands | Authorised | 2009 |
| Afqlir 40 mg/ml oplossing voor injectie in een injectieflaconOplossing voor injectie | Aflibercept | Netherlands | Authorised | 2024 |
| Afqlir 40 mg/ml oplossing voor injectie in een voorgevulde spuitOplossing voor injectie | Aflibercept | Netherlands | Authorised | 2024 |
| AirBuFo Forspiro 160/4,5 microgram/dosis, inhalatiepoeder, voorverdeeldInhalatiepoeder, voorverdeeld | Budesonide, Formoterol | Netherlands | Authorised | 2018 |
| AirBuFo Forspiro 320/9 microgram/dosis, inhalatiepoeder, voorverdeeldInhalatiepoeder, voorverdeeld | Budesonide, Formoterol | Netherlands | Authorised | 2021 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 1,137 | 1,137 | 0 | CompaniesAll medicines |
Also in the registers of Italy, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.